DXB vs ENL

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

40LOW

ENL

ENLITIC CDI FORUS [ENL]

36LOW

Score Breakdown

DXB ENL
Technical
45
42
Catalyst
48
60
Sentiment
50
50
Fundamental
82
37
Momentum
36
44
Risk Gate
50
19

Key Metrics

DXB Metric ENL
$141.1MMarket Cap$5.8M
3.2MAvg Volume (20d)4.1M
N/AShort Interest+0.1%
$0.66552-Week High$0.045
$0.15852-Week Low$0.004
+2.1%Daily Change+0.0%
$0.240Reference Price$0.007
-594.5%ROE-177.1%
-219.9%Profit MarginN/A

Active Signals

DXB Signals

Watch out — volume is flowing out even as price holds up. Distribution pattern
Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
4C filed 2026-04-29
Strong revenue growth (+636%)
EPS estimates revised upward (+10pts)
Near 52-week low (15% of range)

ENL Signals

Volume surging at 2.1x normal while price falls — heavy selling pressure
Beating the Small Ords index — relative strength of 1.25, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (0.9 quarters)
Low P/S ratio (1.5x)
Strong revenue growth (+118%)
Piotroski F-Score weak (3/9, low-confidence approx)
Near 52-week low (6% of range)

Ask Scout AI to compare DXB and ENL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

DXB vs EZZ →DXB vs HIQ →DXB vs ILA →DXB vs MSB →DXB vs MVF →
DXB Full Analysis → ENL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).